FibroGen Inc. | Ownership
Companies that own FibroGen Inc.
Fidelity Management & Research Co.
16,803,656
19.93%
9,983,777
0.1%
06/30/2018
The Vanguard Group, Inc.
6,639,049
7.87%
292,196
0.01%
06/30/2018
BlackRock Fund Advisors
5,611,878
6.65%
252,758
0.02%
06/30/2018
Hillhouse Capital Management Ltd. (Hong Kong)
2,686,196
3.19%
83,850
1.85%
06/30/2018
SSgA Funds Management, Inc.
2,475,018
2.94%
-246,208
0.01%
06/30/2018
T. Rowe Price Associates, Inc.
2,361,134
2.8%
410,993
0.02%
06/30/2018
Ecor1 Capital LLC
2,017,250
2.39%
14,813
12.82%
06/30/2018
Farallon Capital Management LLC
1,717,500
2.04%
0
0.69%
06/30/2018
Henderson Global Investors Ltd.
1,375,983
1.63%
-603,369
0.04%
06/30/2018
First Trust Advisors LP
1,198,925
1.42%
194,766
0.13%
06/30/2018
| Address |
409 Illinois Street
San Francisco California 94158
United States
|
|
Employees
|
- |
| Website |
http://www.fibrogen.com |
| Updated |
07/08/2019 |
| FibroGen, Inc. engages in the discovery, development, and commercialization of therapeutics to treat unmet medical needs. It focuses on fibrosis and hypoxia-induced factor biology to generate programs targeting therapeutic areas. The company was founded by Thomas B. |
